95 related articles for article (PubMed ID: 11299796)
1. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx.
Nordemar S; Kronenwett U; Auer G; Högmo A; Lindholm J; Edström S; Tryggvasson K; Linder S; Munck-Wikland E
Anticancer Res; 2001; 21(1B):509-12. PubMed ID: 11299796
[TBL] [Abstract][Full Text] [Related]
2. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development?
Nordemar S; Högmo A; Lindholm J; Auer G; Munck-Wikland E
Anticancer Res; 2003; 23(6D):4985-9. PubMed ID: 14981956
[TBL] [Abstract][Full Text] [Related]
3. The expression of laminin-5 in severe dysplasia/carcinoma in situ and early invasive squamous cell carcinoma: an immunohistochemical study.
Rahman F; Rao NN; Tippu SR; Patil S; Agarwal S; Srivastava S
Minerva Stomatol; 2013 May; 62(5):139-46. PubMed ID: 23715200
[TBL] [Abstract][Full Text] [Related]
4. Laminin-5 (gamma2 chain) is a marker of invading cancer cells in human gallbladder carcinoma: special emphasis on extension of carcinoma in situ along Rokitansky-Aschoff sinuses.
Eguchi T; Inoue T; Fujii K; Yamaguchi H; Nishiyama K; Yonemasu H; Yao T; Tanaka M; Tsuneyoshi M
Oncol Rep; 2008 Jul; 20(1):33-9. PubMed ID: 18575715
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the glottic larynx.
Myssiorek D; Vambutas A; Abramson AL
Laryngoscope; 1994 Apr; 104(4):463-7. PubMed ID: 8164486
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
10. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
11. 67-kDa laminin receptor in human laryngeal squamous cell carcinoma.
Zhou L; Xie M; Zhou JQ; Tao L
Laryngoscope; 2006 Jan; 116(1):28-32. PubMed ID: 16481804
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus in early laryngeal carcinoma.
Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of chondroitin-6-sulphate and tenascin in the larynx: a loss of chondroitin-6-sulphate expression accompanies squamous cell carcinoma invasion.
Uhlman DL; Niehans GA
J Pathol; 1999 Dec; 189(4):470-4. PubMed ID: 10629545
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract.
Crissman JD; Zarbo RJ
Am J Surg Pathol; 1989; 13 Suppl 1():5-16. PubMed ID: 2699168
[TBL] [Abstract][Full Text] [Related]
15. The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.
Lopez-Beltran A; Luque RJ; Moreno A; Bollito E; Carmona E; Montironi R
Virchows Arch; 2002 Aug; 441(2):148-53. PubMed ID: 12189504
[TBL] [Abstract][Full Text] [Related]
16. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining for markers of future neoplastic progression in the larynx.
Uhlman DL; Adams G; Knapp D; Aeppli DM; Niehans G
Cancer Res; 1996 May; 56(9):2199-205. PubMed ID: 8616872
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
19. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
20. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
Gorban' NA; Ten VP; Pankratov VA
Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
